Orphazyme

Marketing & Advertising

Orphazyme pronounces withdrawal of European Advertising Authorisation Utility for arimoclomol for the therapy of Niemann-Choose illness kind C

Spam - March 22, 2022

Orphazyme A/S Firm announcement No. 13/2022 Inside infowww.orphazyme.com Firm Registration No. 32266355 Choice to withdraw the European Advertising Authorisation Utility comes forward of scheduled ultimate vote on the...

Marketing & Advertising

Orphazyme declares withdrawal of European Advertising

Spam - March 22, 2022

Orphazyme A/SFirm announcementNo. 13/2022Inside infowww.orphazyme.comFirm Registration No. 32266355 Determination to withdraw the European Advertising Authorisation Utility comes forward of scheduled...